Hormone Therapy News

The FDA in June approved a once-weekly human growth hormone analog for children aged 3 years and older with growth hormone deficiency, according to a company press release.

Government-enacted restrictions have resulted in about half of U.S. children and adolescents aged 10 to 17 years living more than 1 hour from a clinic offering gender-confirming care, according to a research letter published in JAMA.

Most transgender youths or children with central precocious puberty had a sustained biochemical response after using a histrelin implant for more than 17 months, according to a study published in Transgender Health.

Past or current use of menopausal hormone therapy is significantly associated with GERD among postmenopausal women, according to results of a systematic review and meta-analysis.

Testosterone use increases risks for cardiovascular disease, coronary artery disease and stroke among cisgender women, but not among transgender adults, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

CHICAGO—In this video exclusive, Vin Tangpricha, MD, PhD, discusses recent legislation prohibiting or seeking to prohibit physicians from providing gender-confirming care.

CHICAGO — Men who stop using anabolic-androgenic steroids may be able to restore their testosterone with the use of post-cycle therapy drugs, according to data presented at ENDO 2023.

CHICAGO — Older men with hypogonadism and high risk for cardiovascular disease who received testosterone therapy had similar rates of CV events as those who received placebo, according to findings from the TRAVERSE trial.

Experts from across the field of endocrinology will converge on Chicago beginning Thursday for the 2023 Endocrine Society annual meeting.

Among postmenopausal women, hormone preparations increased lumbar spine bone mineral density and had a protective effect against osteopenia, according to a real-world study published in Menopause.